Cove Street Capital requires a modern browser to look and function properly. Internet Explorer stopped receiving updates in January 2020. Using it may cause display issues on our website, and put your own online security at risk. We highly recommend switching to a secure modern web browser such as Chrome, Edge, Firefox, or Safari.

Driving the Healthcare Industry to Embrace Non-Invasive Ventilation with Viemed Healthcare CEO Casey Hoyt

Our guest on the show this week was Casey Hoyt, the CEO of Viemed Healthcare (Ticker: VMD). Viemed is a $196 million market cap company that provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. The company has developed a specialty in providing non-invasive ventilation to patients with chronic obstructive pulmonary disease or COPD. Casey took over as CEO in 2017 and has helped the company grow its revenue meaningfully over that time, even accounting for the COVID headwinds the company has seen over the last few years. Given Viemed’s impressive recent track record and the amount of white space it has to continue to serve even more at-risk patients, I was looking forward to talking to Casey about:

  • The elements that have led to such rapid revenue growth;
  • The attractiveness of in-home care relative to acute and outpatient case;
  • The size of the COPD population in the U.S. and how Viemed can increase the penetration of non-invasive ventilation;
  • How the company is attracting and retaining talented people in a very tight labor market for healthcare workers; and
  • How the company thinks about adding new products and services to its current offerings.

*For full disclosure, Cove Street is a Viemed shareholder.

Please enjoy the interview at the following sites:

YouTube: https://www.youtube.com/watch?v=aLsUSgN9Zz8
Apple: https://podcasts.apple.com/us/podcast/driving-the-healthcare-industry-to-embrace-non/id1579124518?i=1000557444547
Spotify: https://open.spotify.com/episode/0u3b7ktMSLmDOef4IgJ1XB
Podbean: https://compounders.podbean.com/e/with-viemed/

Also, if you are interested in learning more about Viemed, my colleagues Eugene Robin and Andrew Leaf did a great interview on the company on the Yet Another Value Podcast.

As always, if you have any comments, feedback, or guest recommendations, please contact us at podcast@covestreetcapital.com. You can also follow the podcast on Twitter @ https://twitter.com/CompoundersPod.

If you missed our last Compounders episode with Mirion Technologies CEO Tom Logan, you can view it here.

Compounders is sponsored by Tegus. With Tegus, you can learn everything you’d want to know about a company on an on-demand digital platform.  Investors share their expert calls, allowing others to instantly access more than 25,000 calls on former Compounders guests such as Viasat, Element Solutions, Avid Technology—or almost any company of interest. All you have to do is log in. If you’re ready to go deeper on any company and you appreciate the value of primary research, head to tegus.co/compounders for a free trial.

Important Notice

You are now leaving Cove Street Capital’s website and entering Cove Street’s Mutual Fund website.